Skip to content

Mobile After-Care Intervention to Support Post-Hospital Transition (MACS)

Mobile After-Care Support Intervention for Patients With Schizophrenia Following Hospitalization (MACS)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03769493
Acronym
MACS
Enrollment
10
Registered
2018-12-07
Start date
2019-01-16
Completion date
2019-10-15
Last updated
2023-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychotic Disorders

Keywords

Medication adherence, Treatment adherence, Ecological momentary assessment, Ecological momentary intervention, Coping skills, Psychiatric Hospitalization

Brief summary

This study examines the feasibility and acceptability of a mobile device-delivered app, called Mobile After-Care Support (MACS), to improve patients' coping and treatment adherence following a hospitalization related to their psychotic-spectrum disorder.

Detailed description

In the open trial, all participants will receive a study-developed app to be used on a mobile phone. This app will support the use of healthy coping skills post-hospitalization, as well as help participants adhere to their discharge treatment plan. This phase is intended to inform the feasibility and acceptability of the app in preparation for a future randomized controlled trial.

Interventions

The MACS app assesses and intervenes by fostering increased treatment adherence (medication/appointments) and self-coping with illness (active, planned, problem-solving focused) to reduce symptoms and improve functioning. Additionally, MACS encourages participants who are already reporting adherence and healthy coping by using positive reinforcement strategies to maintain efforts and promote additional goal setting. MACS app strategies are linked to participants' specific assessment responses, allowing for a highly personalized self-management intervention experience. The MACS app provides interactive exercises delivered by the device designed to teach patients coping skills that they can use now and in the future.

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
Butler Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

An uncontrolled open trial approach will be used in which all participants receive the MACS app.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Currently hospitalized 2. DSM-5 criteria for psychotic disorder (schizophrenia or schizoaffective disorder) 3. 18 years or older 4. Prescribed oral antipsychotic medication upon discharge 5. Ability to speak and read English

Exclusion criteria

1. Alcohol/drug use disorders at moderate or severe level 2. Planned discharge to supervised living setting or participation in formal outpatient adherence programs (e.g., medication packaging) 3. Pregnancy or other medical condition (e.g., dementia) contraindicating use of antipsychotic medications.

Design outcomes

Primary

MeasureTime frameDescription
Client Satisfaction Questionnaire (CSQ)1 monthThe Client Satisfaction Questionnaire is a self-report measure of patient satisfaction with treatment. The total score will be used and ranges from 8 to 32 with increased scores indicating greater satisfaction with treatment.

Secondary

MeasureTime frameDescription
Brief Psychiatric Rating Scale (BPRS)1 monthThe interviewer-rated BPRS is a measure of psychiatric symptom severity. The total score will be used to assess overall severity with scores ranging from 18 to 126 and higher scores indicating greater severity.
Brief Adherence Rating Scale (BARS)1 monthThe BARS assesses the percentage of missed medication doses over the past month. The total adherence score ranges from 0% to 100% and higher scores indicate greater adherence.
Maastricht Assessment of Coping Strategies (MACS)1 monthThe MACS is an interviewer-rated assessment of the coping strategies that patients report using to manage their symptoms.

Countries

United States

Participant flow

Participants by arm

ArmCount
Mobile After-Care Support (MACS) App
All participants will download the MACS app to their mobile phone (or a study provided phone, as needed). The app runs through the third-party platform, mEMA, designed by Ilumivu. It is designed to prompt engagement through questions and tailored responses at multiple times throughout the day and provide brief interventions. Mobile After-Care Support (MACS) app: The MACS app assesses and intervenes by fostering increased treatment adherence (medication/appointments) and self-coping with illness (active, planned, problem-solving focused) to reduce symptoms and improve functioning. Additionally, MACS encourages participants who are already reporting adherence and healthy coping by using positive reinforcement strategies to maintain efforts and promote additional goal setting. MACS app strategies are linked to participants' specific assessment responses, allowing for a highly personalized self-management intervention experience. The MACS app provides interactive exercises delivered by the device designed to teach patients coping skills that they can use now and in the future.
10
Total10

Baseline characteristics

CharacteristicMobile After-Care Support (MACS) App
Age, Continuous44.4 years
STANDARD_DEVIATION 13.9
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
9 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
2 Participants
Race (NIH/OMB)
More than one race
3 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
5 Participants
Region of Enrollment
United States
10 Participants
Sex: Female, Male
Female
6 Participants
Sex: Female, Male
Male
4 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 10
other
Total, other adverse events
0 / 10
serious
Total, serious adverse events
1 / 10

Outcome results

Primary

Client Satisfaction Questionnaire (CSQ)

The Client Satisfaction Questionnaire is a self-report measure of patient satisfaction with treatment. The total score will be used and ranges from 8 to 32 with increased scores indicating greater satisfaction with treatment.

Time frame: 1 month

ArmMeasureValue (MEAN)Dispersion
Mobile After-Care Support (MACS) AppClient Satisfaction Questionnaire (CSQ)19.2 units on a scaleStandard Deviation 1.6
Secondary

Brief Adherence Rating Scale (BARS)

The BARS assesses the percentage of missed medication doses over the past month. The total adherence score ranges from 0% to 100% and higher scores indicate greater adherence.

Time frame: 1 month

ArmMeasureGroupValue (MEAN)Dispersion
Mobile After-Care Support (MACS) AppBrief Adherence Rating Scale (BARS)Baseline96.7 score on a scaleStandard Deviation 8.8
Mobile After-Care Support (MACS) AppBrief Adherence Rating Scale (BARS)1 Month97.5 score on a scaleStandard Deviation 4.6
p-value: 0.875t-test, 2 sided
Secondary

Brief Psychiatric Rating Scale (BPRS)

The interviewer-rated BPRS is a measure of psychiatric symptom severity. The total score will be used to assess overall severity with scores ranging from 18 to 126 and higher scores indicating greater severity.

Time frame: 1 month

ArmMeasureGroupValue (MEAN)Dispersion
Mobile After-Care Support (MACS) AppBrief Psychiatric Rating Scale (BPRS)Baseline46.4 score on a scaleStandard Deviation 6.7
Mobile After-Care Support (MACS) AppBrief Psychiatric Rating Scale (BPRS)1 Month30.4 score on a scaleStandard Deviation 8.5
p-value: <0.001t-test, 2 sided
Secondary

Maastricht Assessment of Coping Strategies (MACS)

The MACS is an interviewer-rated assessment of the coping strategies that patients report using to manage their symptoms.

Time frame: 1 month

Population: No data were collected for this measure (MACS). This is because we were unable to administer the measure as originally planned.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026